Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis

Arthritis and Rheumatism

Volumn 56, Issue 7, 2007, Pages 2443-2448

  Eun, Bong Lee ^a   Zhao, Jinying ^b   Jeong, Yeon Kim ^a   Xiong, Momiao ^c   Yeong, Wook Song ^a,d  

^a Seoul National University   (South Korea)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; RANTES;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

CHEMOKINES; CHEMOKINES, CC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-8; KOREA; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; SCLERODERMA, SYSTEMIC;

EID: 34547447249     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22742     Document Type: Article

References (49)

1. Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis [review]. Autoimmun Rev 2003;2:181-91.
2. Assassi S, Tan FK. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays [review]. Curr Opin Rheumatol 2005;17:761-7.
3. Ahmed SS, Tan FK, Arnett FC. The complex genetics of scleroderma. Am J Med 2002;112:584-6.
4. Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001;44:1359-62.
5. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003;48:1956-63.
6. Yamamoto T. Chemokines and chemokine receptors in scleroderma [review]. Int Arch Allergy Immunol 2006;140:345-56.
7. Tamby MC, Chanseaud Y, Guillevin L, Mouthon L. New insights into the pathogenesis of systemic sclerosis [review]. Autoimmun Rev 2003;2:152-7.
8. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation [review]. N Engl J Med 2006;354:610-21.
9. Atamas SP, White B. The role of chemokines in the pathogenesis of scleroderma [review]. Curr Opin Rheumatol 2003;15:772-7.
10. Karrer S, Bosserhoff AK, Weiderer P, Distler O, Landthaler M, Szeimies RM, et al. The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. J Invest Dermatol 2005;124:92-8.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
12. Renzoni E, Lympany P, Sestini P, Pantelidis P, Wells A, Black C, et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000;43:1633-40.
13. Rovin BH, Lu L, Zhang X. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 2002;62:261-5.
14. Kim HL, Lee DS, Yang SH, Lim CS, Chung JH, Kim S, et al. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 2002;40: 1146-52.
15. Hizawa N, Yamaguchi E, Furuya K, Jinushi E, Ito A, Kawakami Y. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 1999;159:2021-3.
16. Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 2003;26: 892-8.
17. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A 2001;98:5199-204.
18. Weir BS. Genetic data analysis II: methods for discrete population genetic data. Sunderland (MA): Sinauer Associates; 1996.
19. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: design and analysis issues. Mutat Res 2005;573: 54-69.
20. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.
21. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
22. Zhao J, Jin L, Xiong M. Test for interaction between two unlinked loci. Am J Hum Genet 2006;79:831-45.
23. Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: the key to inflammation? [review]. Ann Rheum Dis 2004;63: 1186-94.
24. Rossi D, Zlotnik A. The biology of chemokines and their receptors [review]. Annu Rev Immunol 2000;18:217-42.
25. Villiger PM, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992;149:722-7.
26. Fahey TJ III, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires GT, et al. Macrophage inflammatory protein 1 modulates macrophage function. J Immunol 1992;148:2764-9.
27. Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol 2001;167:5381-5.
28. Koch AE, Kronfeld-Harrington LB, Szekanecz Z, Cho MM, Haines GK, Harlow LA, et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis: their role in early and late disease. Pathobiology 1993; 61:239-46.
29. Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum 1997;40:743-51.
30. Kadono T, Kikuchi K, Ihn H, Takehara K, Tamaki K. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. J Rheumatol 1998;25:296-301.
31. Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, et al. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-α are elevated in patients with systemic sclerosis. J Rheumatol 2003;30:1524-8.
32. Distler O, Rinkes B, Hohenleutner U, Scholmerich J, Landthaler M, Lang B, et al. Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis. Rheumatol Int 1999;19:39-46.
33. Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 1998;89:44-53.
34. Hutyrova B, Lukac J, Bosak V, Buc M, du Bois R, Petrek M. Interleukin la single-nucleotide polymorphism associated with systemic sclerosis. J Rheumatol 2004;31:81-4.
35. Kawaguchi Y, Tochimoto A, Ichikawa N, Harigai M, Hara M, Kotake S, et al. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum 2003;48:186-92.
36. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis 2002;61:678-81.
37. Lee EB, Kim JY, Lee YJ, Abdallah A, Lympany P, Song YW. Transforming growth factor-β1 polymorphisms in Korean patients with systemic sclerosis. Tissue Antigens 2004;63:491-5.
38. Sato H, Lagan AL, Alexopoulou C, Vassilakis DA, Ahmad T, Pantelidis P, et al. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Arthritis Rheum 2004;50:558-64.
39. Tolusso B, Fabris M, Caporali R, Cuomo G, Isola M, Soldano F, et al. -238 and +489 TNF-α along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett 2005;96:103-8.
40. Assassi S, Mayes MD, McNearney T, Fischbach M, Reveille JD, Arnett FC, et al. Polymorphisms of endothelial nitric oxide synthase and angiotensin- converting enzyme in systemic sclerosis. Am J Med 2005;118:907-11.
41. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin Chim Acta 2004;350: 51-5.
42. Fatini C, Gensini F, Sticchi E, Battaglini B, Angotti C, Conforti ML, et al. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med 2002;112:540-4.
43. Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C, et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 2002;46:2990-9.
44. Lagan AL, Pantelidis P, Renzoni EA, Fonseca C, Beirne P, Taegtmeyer AB, et al. Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. Rheumatology (Oxford) 2005;44:197-201.
45. Moore JH. A global view of epistasis. Nat Genet 2005;37:13-4.
46. Thornton-Wells TA, Moore JH, Haines JL. Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet 2004;20:640-7.
47. Nilsson G, Mikovits JA, Metcalfe DD, Taub DD. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/interleukin-8RB. Blood 1999;93:2791-7.
48. Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment interaction to detect genetic associations. Hum Hered 2007;63:111-9.
49. Christner PJ, Jimenez SA. Animal models of systemic sclerosis: insights into systemic sclerosis pathogenesis and potential therapeutic approaches. Curr Opin Rheumatol 2004;16:746-52.